Annual EPS
-$2.19
-$0.60-37.74%
31 December 2023
Summary:
Cara Therapeutics annual earnings per share is currently -$2.19, with the most recent change of -$0.60 (-37.74%) on 31 December 2023. During the last 3 years, it has fallen by -$2.37 (-1316.67%). CARA annual EPS is now -1316.67% below its all-time high of $0.18, reached on 31 December 2020.CARA EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EPS
-$0.23
+$0.14+37.84%
30 September 2024
Summary:
Cara Therapeutics quarterly earnings per share is currently -$0.23, with the most recent change of +$0.14 (+37.84%) on 30 September 2024. Over the past year, it has increased by +$0.29 (+55.77%). CARA quarterly EPS is now -113.61% below its all-time high of $1.69, reached on 31 December 2020.CARA Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EPS
-$1.75
+$0.29+14.22%
30 September 2024
Summary:
Cara Therapeutics TTM earnings per share is currently -$1.75, with the most recent change of +$0.29 (+14.22%) on 30 September 2024. Over the past year, it has increased by +$0.40 (+18.60%). CARA TTM EPS is now -396.61% below its all-time high of $0.59, reached on 30 September 2021.CARA TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CARA EPS Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -37.7% | +55.8% | +18.6% |
| 3 y3 years | -1316.7% | -1050.0% | -396.6% |
| 5 y5 years | -6.3% | +68.9% | +27.1% |
CARA EPS High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -1316.7% | at low | -1050.0% | +63.5% | -396.6% | +22.2% |
| 5 y | 5 years | -1316.7% | +12.1% | -113.6% | +68.9% | -396.6% | +31.4% |
| alltime | all time | -1316.7% | +12.1% | -113.6% | +71.6% | -396.6% | +31.4% |
Cara Therapeutics EPS History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$0.23(-37.8%) | -$1.75(-14.2%) |
| June 2024 | - | -$0.37(-33.9%) | -$2.04(-9.3%) |
| Mar 2024 | - | -$0.56(-5.1%) | -$2.25(+3.2%) |
| Dec 2023 | -$2.19(+37.7%) | -$0.59(+13.5%) | -$2.18(+1.4%) |
| Sept 2023 | - | -$0.52(-10.3%) | -$2.15(+4.4%) |
| June 2023 | - | -$0.58(+18.4%) | -$2.06(+32.1%) |
| Mar 2023 | - | -$0.49(-12.5%) | -$1.56(-1.9%) |
| Dec 2022 | -$1.59(-8.6%) | -$0.56(+30.2%) | -$1.59(-4.2%) |
| Sept 2022 | - | -$0.43(+437.5%) | -$1.66(+32.8%) |
| June 2022 | - | -$0.08(-84.6%) | -$1.25(-29.8%) |
| Mar 2022 | - | -$0.52(-17.5%) | -$1.78(+2.9%) |
| Dec 2021 | -$1.74(-1066.7%) | -$0.63(+3050.0%) | -$1.73(-393.2%) |
| Sept 2021 | - | -$0.02(-96.7%) | $0.59(+126.9%) |
| June 2021 | - | -$0.61(+29.8%) | $0.26(-21.2%) |
| Mar 2021 | - | -$0.47(-127.8%) | $0.33(+83.3%) |
| Dec 2020 | $0.18(-107.2%) | $1.69(-582.9%) | $0.18(-108.5%) |
| Sept 2020 | - | -$0.35(-35.2%) | -$2.12(-15.5%) |
| June 2020 | - | -$0.54(-12.9%) | -$2.51(-1.6%) |
| Mar 2020 | - | -$0.62(+1.6%) | -$2.55(+2.4%) |
| Dec 2019 | -$2.49(+20.9%) | -$0.61(-17.6%) | -$2.49(+3.8%) |
| Sept 2019 | - | -$0.74(+27.6%) | -$2.40(+10.6%) |
| June 2019 | - | -$0.58(+3.6%) | -$2.17(+2.8%) |
| Mar 2019 | - | -$0.56(+7.7%) | -$2.11(+2.4%) |
| Dec 2018 | -$2.06 | -$0.52(+2.0%) | -$2.06(+4.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | -$0.51(-1.9%) | -$1.97(+7.1%) |
| June 2018 | - | -$0.52(+2.0%) | -$1.84(+14.3%) |
| Mar 2018 | - | -$0.51(+18.6%) | -$1.61(-15.7%) |
| Dec 2017 | -$1.86(-11.4%) | -$0.43(+13.2%) | -$1.91(-16.6%) |
| Sept 2017 | - | -$0.38(+31.0%) | -$2.29(-1.7%) |
| June 2017 | - | -$0.29(-64.2%) | -$2.33(-7.5%) |
| Mar 2017 | - | -$0.81(0.0%) | -$2.52(+20.0%) |
| Dec 2016 | -$2.10(+110.0%) | -$0.81(+92.9%) | -$2.10(+28.0%) |
| Sept 2016 | - | -$0.42(-12.5%) | -$1.64(+16.3%) |
| June 2016 | - | -$0.48(+23.1%) | -$1.41(+19.5%) |
| Mar 2016 | - | -$0.39(+11.4%) | -$1.18(+18.0%) |
| Dec 2015 | -$1.00(+17.6%) | -$0.35(+84.2%) | -$1.00(+20.5%) |
| Sept 2015 | - | -$0.19(-24.0%) | -$0.83(-10.8%) |
| June 2015 | - | -$0.25(+19.0%) | -$0.93(+10.7%) |
| Mar 2015 | - | -$0.21(+16.7%) | -$0.84(-1.2%) |
| Dec 2014 | -$0.85(+504.6%) | -$0.18(-37.9%) | -$0.85(+11.0%) |
| Sept 2014 | - | -$0.29(+81.3%) | -$0.77(-37.0%) |
| June 2014 | - | -$0.16(-27.3%) | -$1.22(+48.6%) |
| Mar 2014 | - | -$0.22(+129.6%) | -$0.82(-7.0%) |
| Dec 2013 | -$0.14(-86.1%) | -$0.10(-87.1%) | -$0.88(-18.1%) |
| Sept 2013 | - | -$0.74(-411.6%) | -$1.07(+221.0%) |
| June 2013 | - | $0.24(-184.3%) | -$0.33(-41.5%) |
| Mar 2013 | - | -$0.28(-3.1%) | -$0.57(+96.9%) |
| Dec 2012 | -$1.01(-36.1%) | -$0.29 | -$0.29 |
| Dec 2011 | -$1.59 | - | - |
FAQ
- What is Cara Therapeutics annual earnings per share?
- What is the all time high annual EPS for Cara Therapeutics?
- What is Cara Therapeutics annual EPS year-on-year change?
- What is Cara Therapeutics quarterly earnings per share?
- What is the all time high quarterly EPS for Cara Therapeutics?
- What is Cara Therapeutics quarterly EPS year-on-year change?
- What is Cara Therapeutics TTM earnings per share?
- What is the all time high TTM EPS for Cara Therapeutics?
- What is Cara Therapeutics TTM EPS year-on-year change?
What is Cara Therapeutics annual earnings per share?
The current annual EPS of CARA is -$2.19
What is the all time high annual EPS for Cara Therapeutics?
Cara Therapeutics all-time high annual earnings per share is $0.18
What is Cara Therapeutics annual EPS year-on-year change?
Over the past year, CARA annual earnings per share has changed by -$0.60 (-37.74%)
What is Cara Therapeutics quarterly earnings per share?
The current quarterly EPS of CARA is -$0.23
What is the all time high quarterly EPS for Cara Therapeutics?
Cara Therapeutics all-time high quarterly earnings per share is $1.69
What is Cara Therapeutics quarterly EPS year-on-year change?
Over the past year, CARA quarterly earnings per share has changed by +$0.29 (+55.77%)
What is Cara Therapeutics TTM earnings per share?
The current TTM EPS of CARA is -$1.75
What is the all time high TTM EPS for Cara Therapeutics?
Cara Therapeutics all-time high TTM earnings per share is $0.59
What is Cara Therapeutics TTM EPS year-on-year change?
Over the past year, CARA TTM earnings per share has changed by +$0.40 (+18.60%)